National Myeloma Month 2022 - Online Seminar May 17 Survey

Question Title

* 1. Are you a ....

Person with myeloma

Family Member

Carer

Friend

Health Professional

Question Title

* 2. Are you?

Male

Female

Non-binary

Prefer not to say

Question Title

* 3. Are you of Aboriginal or Torres Strait Islander origin?

Yes, Aboriginal

Yes, Torres Strait Islander

Yes, both Aboriginal & Torres Strait Islander

Question Title

* 4. Do you identify as someone from a culturally & linguistically diverse background?

Yes

If yes, please specify

Question Title

* 5. What is your age?

18-24

25-34

35-44

45-54

55-64

65+

Question Title

* 6. Which state do you live in?

NSW

VIC

QLD

TAS

ACT

Other

Question Title

* 7. Where do you reside?

Metro

Regional

Rural / Remote

Question Title

* 8. How did you find out about this online seminar?

Myeloma Australia Email Invitation

Myeloma Australia Website

Myeloma Australia's Newsletter - The Muster

Social Media / Facebook

A health professional

A relative, friend or patient

Other (please specify)

Question Title

* 9. Have you ever attended any other online seminar / webinar before?

Yes

Please describe:

Question Title

* 10. Did you watch the online seminar live or after the event on playback?

Live

Playback

A mixture of both live and playback

Question Title

* 11. What best describes your main reason for watching today? (Tick all that apply)

To learn about myeloma and its treatment

To learn more about the services and support available

To help make decisions about my treatment

To ask questions of health professionals at the seminar

To feel connected to the myeloma community

To learn to live well with myeloma

Other (please specify)

Question Title

* 12. How easy did you find the process of logging on to the online seminar?

Very Easy

Very Difficult

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 13. How much information within each presentation did you understand?

	All of it	Most of it	Some of it	Very little
New Treatment - Dr Nick Murphy	New Treatment - Dr Nick Murphy All of it	New Treatment - Dr Nick Murphy Most of it	New Treatment - Dr Nick Murphy Some of it	New Treatment - Dr Nick Murphy Very little
CAR-T Cell Therapy - Dr Shafqat Inam	CAR-T Cell Therapy - Dr Shafqat Inam All of it	CAR-T Cell Therapy - Dr Shafqat Inam Most of it	CAR-T Cell Therapy - Dr Shafqat Inam Some of it	CAR-T Cell Therapy - Dr Shafqat Inam Very little
Cancer Related Cognitive Impairment - Elizabeth Wells	Cancer Related Cognitive Impairment - Elizabeth Wells All of it	Cancer Related Cognitive Impairment - Elizabeth Wells Most of it	Cancer Related Cognitive Impairment - Elizabeth Wells Some of it	Cancer Related Cognitive Impairment - Elizabeth Wells Very little

Other comments

Question Title

* 14. How personally useful was the information in the presentation?

	All of it	Most of it	Some of it	Very little
New Treatment - Dr Nick Murphy	New Treatment - Dr Nick Murphy All of it	New Treatment - Dr Nick Murphy Most of it	New Treatment - Dr Nick Murphy Some of it	New Treatment - Dr Nick Murphy Very little
CAR-T Cell Therapy - Dr Shafqat Inam	CAR-T Cell Therapy - Dr Shafqat Inam All of it	CAR-T Cell Therapy - Dr Shafqat Inam Most of it	CAR-T Cell Therapy - Dr Shafqat Inam Some of it	CAR-T Cell Therapy - Dr Shafqat Inam Very little
Cancer Related Cognitive Impairment - Elizabeth Wells	Cancer Related Cognitive Impairment - Elizabeth Wells All of it	Cancer Related Cognitive Impairment - Elizabeth Wells Most of it	Cancer Related Cognitive Impairment - Elizabeth Wells Some of it	Cancer Related Cognitive Impairment - Elizabeth Wells Very little

Other comments

Question Title

* 15. How do you rate the seminar overall?

Poor

Good

Excellent

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 16. How valuable to you is Myeloma Australia in delivering these education events?

Not Important

Indifferent

Extremely Important

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 17. On a scale of 1-10, how likely are you to recommend Myeloma Australia education events to others?

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 18. Please tell us why you gave the rating you chose in the previous question (Q17)

Question Title

* 19. Do you have any other comments or feedback to offer? ie what was good, what could be improved, future topic suggestions for Myeloma Australia education events?

The team at Myeloma Australia thank you for taking the time to complete this survey.